ANTI-PM/SCL 75 AND ANTI-PM/SCL 100 ANTIBODIES: DOES THE NUMBER MATTER?

被引:0
|
作者
Santos, B. [1 ]
Basto, A. [2 ]
Reboredo, A. [3 ]
Barcelos, A. [1 ]
机构
[1] Ctr Hosp Baixo Vouga, Dept Rheumatol, Aveiro, Portugal
[2] Univ Porto, Abel Salazar Biomed Sci Inst, Anim Sci, Porto, Portugal
[3] Ctr Hosp Baixo Vouga, Dept Clin Pathol, Aveiro, Portugal
关键词
D O I
10.1136/annrheumdis-2022-eular.5273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0749
引用
收藏
页码:1499 / 1499
页数:1
相关论文
共 50 条
  • [1] The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis
    Wielosz, Ewa
    Dryglewska, Magdalena
    Majdan, Maria
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2021, 28 (01) : 189 - 192
  • [2] Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma
    Maes, L.
    Blockmans, D.
    Verschueren, P.
    Westhovens, R.
    De Beeck, K. Op
    Vermeersch, P.
    Van den Bergh, K.
    Burlingame, R. W.
    Mahler, M.
    Bossuyt, X.
    CLINICA CHIMICA ACTA, 2010, 411 (13-14) : 965 - 971
  • [3] Image Gallery: Palmoplantar hyperkeratosis in dermatomyositis with anti-PM/Scl antibodies
    Taki, T.
    Muro, Y.
    Ogawa, Y.
    Akiyama, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (05) : E94 - E94
  • [4] Clinical heterogeneity of anti-PM/Scl positive conditions
    Ruiz Sada, Pablo
    Palacios Garcia, Lara
    Esquillor Rodrigo, Maria-Jose
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (09) : 532 - 533
  • [5] Anti-PM/Scl and hypomyopathic dermatomyositis: a novel association
    Allegro, E.
    Fassio, F.
    Salvati, G.
    De Giorgi, G.
    Troilo, A.
    Parronchi, P.
    Maggi, E.
    ALLERGY, 2013, 68 : 198 - 198
  • [6] THE CLINICAL CONSEQUENCES PRESENCE OF ANTI-PM/SCL ANTIBODIES IN SYSTEMIC SCLEROSIS
    Wielosz, E.
    Dryglewska, M.
    Majdan, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1273 - 1273
  • [7] Scleroderma Renal Crisis in a Systemic Sclerosis With Anti-PM/Scl Antibodies
    Jacquier, Marine
    Mousson, Christiane
    Rebibou, Jean-Michel
    Lakomy, Daniela
    Francois, Stephanie
    Martin, Laurent
    De la Vega, Mathilde Funes
    Legendre, Mathieu
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (10): : 1499 - 1502
  • [8] ASSOCIATION OF ANTI-PM/SCL ANTIBODY WITH RISK OF MALIGNANCY IN SCLERODERMA
    Bruni, Cosimo
    Lages, Ana
    Patel, Hitesh
    Harvey, Jennifer
    Ong, Voon
    Matucci-Cerinic, Marco
    Derrett-Smith, Emma
    Denton, Christopher P.
    RHEUMATOLOGY, 2015, 54 : 60 - 60
  • [9] Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM/Scl antibodies
    Zhu, Longyang
    Zong, Chen
    Chen, Yiran
    Wang, Guochun
    Ge, Yongpeng
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 68
  • [10] ASSOCIATION OF ANTI-PM/SCL ANTIBODY WITH RISK OF MALIGNANCY IN SCLERODERMA
    Bruni, C.
    Lages, A.
    Patel, H.
    Harvey, J.
    Ong, V.
    Cerinic, M. Matucci
    Derrett-Smith, E.
    Denton, C. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 593 - 594